Literature DB >> 8816995

Mitogenesis, cell migration, and loss of focal adhesions induced by tenascin-C interacting with its cell surface receptor, annexin II.

C Y Chung1, J E Murphy-Ullrich, H P Erickson.   

Abstract

In a previous study we demonstrated that the alternatively spliced region of tenascin-C, TNfnA-D, bound with high affinity to a cell surface receptor, annexin II. In the present study we demonstrate three changes in cellular activity that are produced by adding intact tenascin-C or TNfnA-D to cells, and we show that all three activities are blocked by antibodies against annexin II. 1) TNfnA-D added to confluent endothelial cells induced loss of focal adhesions. 2) TNfnA-D produced a mitogenic response of confluent, growth-arrested endothelial cells in 1% serum. TNfnA-D stimulated mitogenesis only when it was added to cells before or during exposure to other mitogens, such as basic fibroblast growth factor or serum. Thus the effect of TNfnA-D seems to be to facilitate the subsequent response to growth factors. 3) TNfnA-D enhanced cell migration in a cell culture wound assay. Antibodies to annexin II blocked all three cellular responses to TNfnA-D. These data show that annexin II receptors on endothelial cells mediate several cell regulatory functions attributed to tenascin-C, potentially through modulation of intracellular signalling pathways.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8816995      PMCID: PMC275940          DOI: 10.1091/mbc.7.6.883

Source DB:  PubMed          Journal:  Mol Biol Cell        ISSN: 1059-1524            Impact factor:   4.138


  32 in total

1.  Purification of hexabrachion (tenascin) from cell culture conditioned medium, and separation from a cell adhesion factor.

Authors:  I Aukhil; C C Slemp; V A Lightner; K Nishimura; G Briscoe; H P Erickson
Journal:  Matrix       Date:  1990-05

Review 2.  Tenascin in normal, reactive, hyperplastic, and neoplastic tissues: biologic and pathologic implications.

Authors:  G K Koukoulis; V E Gould; A Bhattacharyya; J E Gould; A A Howeedy; I Virtanen
Journal:  Hum Pathol       Date:  1991-07       Impact factor: 3.466

3.  Cytotactin binding: inhibition of stimulated proliferation and intracellular alkalinization in fibroblasts.

Authors:  K L Crossin
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-15       Impact factor: 11.205

4.  Protein kinase C activation during corneal endothelial wound repair.

Authors:  N C Joyce; B Meklir
Journal:  Invest Ophthalmol Vis Sci       Date:  1992-05       Impact factor: 4.799

5.  Mice develop normally without tenascin.

Authors:  Y Saga; T Yagi; Y Ikawa; T Sakakura; S Aizawa
Journal:  Genes Dev       Date:  1992-10       Impact factor: 11.361

6.  Tenascin: a modulator of cell growth.

Authors:  P End; G Panayotou; A Entwistle; M D Waterfield; M Chiquet
Journal:  Eur J Biochem       Date:  1992-11-01

7.  Expression of different tenascin isoforms in normal, hyperplastic and neoplastic human breast tissues.

Authors:  L Borsi; B Carnemolla; G Nicolò; B Spina; G Tanara; L Zardi
Journal:  Int J Cancer       Date:  1992-11-11       Impact factor: 7.396

8.  Phorbol ester-induced actin cytoskeletal reorganization requires a heavy metal ion.

Authors:  K K Hedberg; G B Birrell; O H Griffith
Journal:  Cell Regul       Date:  1991-12

9.  Cell- and heparin-binding domains of the hexabrachion arm identified by tenascin expression proteins.

Authors:  I Aukhil; P Joshi; Y Yan; H P Erickson
Journal:  J Biol Chem       Date:  1993-02-05       Impact factor: 5.157

10.  The extracellular matrix of lip wounds in fetal, neonatal and adult mice.

Authors:  D J Whitby; M W Ferguson
Journal:  Development       Date:  1991-06       Impact factor: 6.868

View more
  59 in total

Review 1.  The de-adhesive activity of matricellular proteins: is intermediate cell adhesion an adaptive state?

Authors:  J E Murphy-Ullrich
Journal:  J Clin Invest       Date:  2001-04       Impact factor: 14.808

2.  Suppression subtractive hybridization identifies distinctive expression markers for coronary and internal mammary arteries.

Authors:  Minghui Qin; Zhaohui Zeng; Jie Zheng; Prediman K Shah; Stephen M Schwartz; Lawrence D Adams; Behrooz G Sharifi
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-01-30       Impact factor: 8.311

3.  Novel human alpha9 acetylcholine receptor regulating keratinocyte adhesion is targeted by Pemphigus vulgaris autoimmunity.

Authors:  V T Nguyen; A Ndoye; S A Grando
Journal:  Am J Pathol       Date:  2000-10       Impact factor: 4.307

4.  Annexin A6 contributes to the invasiveness of breast carcinoma cells by influencing the organization and localization of functional focal adhesions.

Authors:  Amos M Sakwe; Rainelli Koumangoye; Bobby Guillory; Josiah Ochieng
Journal:  Exp Cell Res       Date:  2010-12-24       Impact factor: 3.905

5.  Cell-adhesive responses to tenascin-C splice variants involve formation of fascin microspikes.

Authors:  D Fischer; R P Tucker; R Chiquet-Ehrismann; J C Adams
Journal:  Mol Biol Cell       Date:  1997-10       Impact factor: 4.138

6.  Anti-beta2GPI-antibody-induced endothelial cell gene expression profiling reveals induction of novel pro-inflammatory genes potentially involved in primary antiphospholipid syndrome.

Authors:  C Hamid; K Norgate; D P D'Cruz; M A Khamashta; M Arno; J D Pearson; G Frampton; J J Murphy
Journal:  Ann Rheum Dis       Date:  2007-01-12       Impact factor: 19.103

Review 7.  Matricellular proteins in cardiac adaptation and disease.

Authors:  Nikolaos G Frangogiannis
Journal:  Physiol Rev       Date:  2012-04       Impact factor: 37.312

8.  Tenascin immunoreactivity in the large bowel and the liver in patients with colorectal cancer.

Authors:  M V Gulubova; T Vlaykova
Journal:  Histochem J       Date:  2001-02

9.  Tenascin-C promotes healing of Habu-snake venom-induced glomerulonephritis: studies in knockout congenic mice and in culture.

Authors:  N Nakao; N Hiraiwa; A Yoshiki; F Ike; M Kusakabe
Journal:  Am J Pathol       Date:  1998-05       Impact factor: 4.307

10.  Expression of tenascin-C in aseptic loosening of total hip replacement.

Authors:  Y T Konttinen; T F Li; O Michelsson; J W Xu; T Sorsa; S Santavirta; S Imai; I Virtanen
Journal:  Ann Rheum Dis       Date:  1998-10       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.